3 Biotech Companies Down But Not Out

When it comes to speculative biotech investing, one can at times make a connection to the sport of boxing. What often occurs with these companies is that for one reason or another they suffer major setbacks. These setbacks can occur for a variety of reason. Prime examples are massive equity dilution, FDA rejection letters, clinical trial failures, plus a whole host of other unique events. The big question on investor's minds is if these knocked down companies can pick themselves back up and continue the fight. Watching these investing stories play out reminds me of an old boxing match between Joe Jeannette and Sam McVey in Paris on April 17 1909. In this 50 round fight to the finish Jeannette was floored 27 times. It was said that Jeannette hit the canvas 21 times in the first 19 rounds and after the 17th round bell had to be dragged to